BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 36749262)

  • 21. Cystic neoplasia of the pancreas: pathology and biology.
    Adsay NV
    J Gastrointest Surg; 2008 Mar; 12(3):401-4. PubMed ID: 17957438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.
    Sahora K; Fernández-del Castillo C; Dong F; Marchegiani G; Thayer SP; Ferrone CR; Sahani DV; Brugge WR; Warshaw AL; Lillemoe KD; Mino-Kenudson M
    Surgery; 2014 Sep; 156(3):611-21. PubMed ID: 25081232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Threshold of main pancreatic duct for malignancy in intraductal papillary mucinous neoplasm at head-neck and body-tail.
    Zhou H; Li X; Wang Y; Wang Z; Zhu J; Wang Z; Chen X
    BMC Gastroenterol; 2022 Nov; 22(1):473. PubMed ID: 36402960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of malignancy in main duct or mixed-type intraductal papillary mucinous neoplasms of the pancreas.
    Jung HS; Han Y; Kang JS; Sohn H; Lee M; Lee KB; Kim H; Kwon W; Jang JY
    J Hepatobiliary Pancreat Sci; 2022 Sep; 29(9):1014-1024. PubMed ID: 35451206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between CT patterns and pathological classification of intraductal papillary mucinous neoplasm.
    Zhang J; Wang PJ; Yuan XD
    Eur J Radiol; 2010 Jan; 73(1):96-101. PubMed ID: 19008065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
    Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules.
    Sadakari Y; Ienaga J; Kobayashi K; Miyasaka Y; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Pancreas; 2010 Mar; 39(2):232-6. PubMed ID: 19752768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serous cystadenoma in communication with the pancreatic duct: an unusual radiologic and pathologic entity.
    Berman L; Mitchell KA; Israel G; Salem RR
    J Clin Gastroenterol; 2010 Jul; 44(6):e133-5. PubMed ID: 20216080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI findings of intraductal papillary mucinous neoplasms (IPMNs).
    Lana S; Vallara M; Bono NE; Russo G; Artioli G; Capretti G; Paladini I; Pesce A; Ruggirello M; Barbalace S; Mostardi M
    Acta Biomed; 2016 Jul; 87 Suppl 3():28-33. PubMed ID: 27467864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Khannoussi W; Vullierme MP; Rebours V; Maire F; Hentic O; Aubert A; Sauvanet A; Dokmak S; Couvelard A; Hammel P; Ruszniewski P; Lévy P
    Pancreatology; 2012; 12(3):198-202. PubMed ID: 22687372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report.
    Lee CJ; Scheiman J; Anderson MA; Hines OJ; Reber HA; Farrell J; Kochman ML; Foley PJ; Drebin J; Oh YS; Ginsberg G; Ahmad N; Merchant NB; Isbell J; Parikh AA; Stokes JB; Bauer T; Adams RB; Simeone DM
    J Gastrointest Surg; 2008 Feb; 12(2):234-42. PubMed ID: 18040749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
    Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
    Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic Cystic Tumors: A Single-Center Observational Study.
    Jabłońska B; Gudz A; Hinborch T; Bujała B; Biskup K; Mrowiec S
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837443
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical Outcomes of Intraductal Papillary Mucinous Neoplasms With Dilatation of the Main Pancreatic Duct.
    Hamada T; Oyama H; Nakai Y; Tange S; Arita J; Hakuta R; Ijichi H; Ishigaki K; Kanai S; Kawaguchi Y; Kogure H; Mizuno S; Saito K; Saito T; Sato T; Suzuki T; Takahara N; Tanaka M; Tateishi K; Ushiku T; Hasegawa K; Fujishiro M
    Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1792-1801.e3. PubMed ID: 36787835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
    Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
    Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions.
    Räty S; Sand J; Laukkarinen J; Vasama K; Bassi C; Salvia R; Nordback I
    Pancreatology; 2013; 13(5):530-3. PubMed ID: 24075519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Case of Serous Cystadenoma Communicating with a Stenotic Santorini's Duct and a Dilated Main Pancreatic Duct.
    Matsubayashi H; Oka Y; Ito T; Uesaka K; Sasaki K; Ono H
    J Gastrointestin Liver Dis; 2016 Dec; 25(4):551-554. PubMed ID: 27981313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
    Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
    Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
    Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
    Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
    Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
    Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.